Autoimmune tests in primary biliary cirrhosis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 4, 2000, Pages 585-599

  Strassburg, Christian P ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antimitochondrial antibodies; Antinuclear antibodies; Cyclin A; Gp210; Ketoacid dehydrogenase; M2 antigen; Predictive value; Sp100

Indexed keywords

ANTINUCLEAR ANTIBODY; MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE;

ADULT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; RAT; RECURRENCE RISK; SERODIAGNOSIS; TREATMENT PLANNING; WESTERN BLOTTING;

EID: 0033785285     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2000.0105     Document Type: Article

References (80)

1. Immunogenetics in liver disease
2. The nature of autoimmune disease
3. The epidemiology of primary biliary cirrhosis: Immunological problems
4. Familial primary biliary cirrhosis
5. Familial primary biliary cirrhosis reassessed: A geographically-based population study
6. Familial primary biliary cirrhosis. Immunological and genetic study
7. Familial primary biliary cirrhosis in Hiroshima
8. Chromosomal aberrations in patients with primary biliary cirrhosis
9. Immunogenetics of chronic liver diseases
10. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis
11. Defining the immunogenetic susceptibility to primary biliary cirrhosis
12. DNA typing of HLA class II genes; DRB1·0803 increases the susceptibility of Japanese to primary biliary cirrhosis
13. TNF gene polymorphisms in primary biliary cirrhosis: A critical appraisal
14. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region
15. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: Revisited
16. Primary biliary cirrhosis showing a high titer of autoantibody
17. A mitochondrial antigen-antibody system in cholestatic liver disease detected by radioimmunoassay
18. Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis
19. Primary biliary cirrhosis and mitochondrial autoantigens-insights from molecular biology
20. Primary biliary cirrhosis: Paradigm or paradox for autoimmunity
21. Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease
22. Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis
23. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis
24. Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis
25. Primary biliary cirrhosis: Survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years
26. Immunopathology of primary biliary cirrhosis
27. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex
28. The role of T cells in primary biliary cirrhosis
29. Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes
30. Mitochondrial antigens and autoantibodies: From anti-M1 to anti-M9
31. Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: Definition of two novel mitochondrial polypeptide autoantigens
32. Multiplicity of mitochondrial inner membrane antigens from beef heart reacting with antimitochondrial antibodies in sera of patients with primary biliary cirrhosis
33. Mitochondrial antibodies in primary biliary cirrhosis: Species and nonspecies specific determinants of M2 antigen
34. Characterization of primary biliary cirrhosis (PBC) specific mitochondrial determinants by immunoblotting
35. Characterization of primary biliary cirrhosis (PBC) specific mitochondrial determinants by immunoblotting
36. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis
37. Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies
38. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase
39. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope
40. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex
41. Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis
42. Molecular aspects and the pathological basis of primary biliary cirrhosis
43. Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis
44. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis
45. Subcellular localization of pyruvate dehydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells
46. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis
47. Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years
48. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: A prospective study on 200 patients followed for 10 years
49. Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space
50. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: Epitopes or epiphenomena?
51. M4 and M9 autoantigens in primary biliary cirrhosis - A negative study
52. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: Relationship of levels of autoantibodies to disease progression
53. Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation
54. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis
55. Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors
56. Clinical relevance of recurrence of primary biliary cirrhosis after liver transplantation
57. Chronic hepatitis
58. Immunological, serological and molecular biological tests in liver diseases
59. Antinuclear antibodies (ANAs): Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity
60. Structural and functional heterogeneity of nuclear bodies
61. Primary biliary cirrhosis and the molecular cell biology of the nuclear envelope
62. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis
63. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis
64. Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation
65. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis
66. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210
67. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis
68. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100)
69. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: Epitope specificity and immunoglobulin class distribution
70. Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology
71. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic diseases
72. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR
73. Two nuclear dot associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis
74. Frequency and nature of the variant syndromes of autoimmune liver disease
75. Meeting report: International autoimmune hepatitis group
76. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis
77. Autoimmune cholangitis: A variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases
78. Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
79. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis
80. Autoimmune cholangiopathy: The result of consecutive primary biliary cirrhosis and autoimmune hepatitis?